Great response! I think the FDA has said through their actions that they will not approve Leronlimab for anything with out a straight out P value result (Remdesivir and BP drugs clearly do not need to prove this and de facto it means that the FDA is slow rolling cydy) in a stand alone trial with a large cohort. As far as I’m concerned this is now fact. I also think they have zero respect for Nader and would prefer not to do business with him.

As far as the world goes I think the Philippines are the only real immediate hope. They are small enough that they may not care about offending the US FDA. Most other countries are VERY afraid. They would rather see a faceless killer named coved kill many than be personally responsible for approving a drug as safe as Leronlimab even if it killed one person...which it won’t.

So unless they can sell in the Philippines how does this company survive? Where does the money come from? As an investor that can crush it in growth stocks time decay (theta) is eating shareholders alive in cydy. Even if they sell in the Philippines without the FDA (cancer, HIV) how do they make revs? I am waiting for the Phillipine decision. If it is no then I’m a seller (yay the board will be rid of me) if yes then I would like a buyout or new management.